Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Unknown × patritumab deruxtecan × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

fludarabine 17 Cyclophosphamide 16 Positron Emission Tomography Computed Tomography 4 Paclitaxel 4 Oncolytic Virotherapy 4 Metformin 4 Gemcitabine 4 Carboplatin 4 68Ga-pentixafor 4 pembrolizumab 3 lenvatinib 3 Radiosurgery 3 Pemetrexed 3 Nivolumab 3 Melphalan 3 Immunotherapy, Adoptive 3 Cisplatin 3 Cholestanetriol 26-Monooxygenase 3 Bevacizumab 3 toripalimab 2 sintilimab 2 gallium Ga 68 dotatate 2 gallium 68 PSMA-11 2 fludarabine phosphate 2 alpha-Synuclein 2 Radiotherapy 2 Radiation 2 Progesterone 2 Neoadjuvant Therapy 2 Magnetic Resonance Spectroscopy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04610528 2023-06-23

TOT-HER3

SOLTI Breast Cancer Research Group

Phase EARLY_PHASE1 Unknown

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡